VIVE

VIVEVE MEDICAL, INC.
CAPPED RATING

Viveve Medical, Inc. engages in the provision of health products. Its activities include development and distribution of women\'s health solutions. Its products include non-surgical, non-ablative medical device that remodels collagen and restores vaginal tissue. The company was founded on March 3, 1987 and is headquartered Englewood, CO.

VIVEVE MEDICAL, INC. (VIVE) is rated C- (2.1/5) on Deltasharpe Prism, scored against General sector peers. Its strongest pillar is Momentum (C+); its weakest is Profitability (D). The rating has held at C- for 278 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.1 / 5.0
C-
Value
C+
Factor Score 2.5 / 5.0
Growth
C
Factor Score 2.2 / 5.0
Profitability
D
Factor Score 1.5 / 5.0
Momentum
C+
Factor Score 2.8 / 5.0
Revisions
D+
Factor Score 1.5 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA N/A
Rev Growth YoY 4.2%
Gross Margin 32.4%
Price Return 3M 0.0%
Price Return 12M 100.0%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales N/A
ROE -420.3%

Historical Factor Score Progression

Held C- for 278 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-07-29 C+ (2.5) C (2.2) D (1.5) C+ (2.8) D+ (1.5) C- (2.1)
2022-09-30 C+ (2.5) C- (1.9) D+ (1.6) C+ (2.7) D (1.5) C- (2.0)
2022-06-30 C+ (2.5) C- (1.9) C- (2.0) C+ (2.7) D (1.5) C- (2.1)
2022-03-31 C+ (2.5) C- (2.0) C- (2.1) C+ (2.7) D (1.5) C- (2.1)
2021-12-31 C+ (2.5) D- (1.1) D+ (1.8) C+ (2.7) D (1.5) C- (1.9)
Page 1 of 2